These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33103628)

  • 1. From osteoporosis to pseudoxanthoma elasticum - etidronate in a vascular disease.
    Stumpf MJ; Schaefer CA; Schahab N
    Vasa; 2020 Oct; 49(6):520. PubMed ID: 33103628
    [No Abstract]   [Full Text] [Related]  

  • 2. Etidronate for Prevention of Ectopic Mineralization in Patients With Pseudoxanthoma Elasticum.
    Kranenburg G; de Jong PA; Bartstra JW; Lagerweij SJ; Lam MG; Ossewaarde-van Norel J; Risseeuw S; van Leeuwen R; Imhof SM; Verhaar HJ; de Vries JJ; Slart RHJA; Luurtsema G; den Harder AM; Visseren FLJ; Mali WP; Spiering W
    J Am Coll Cardiol; 2018 Mar; 71(10):1117-1126. PubMed ID: 29519353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etidronate halts systemic arterial calcification in pseudoxanthoma elasticum.
    Bartstra JW; de Jong PA; Kranenburg G; Wolterink JM; Isgum I; Wijsman A; Wolf B; den Harder AM; Mali WPTM; Spiering W
    Atherosclerosis; 2020 Jan; 292():37-41. PubMed ID: 31756632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Mineralization in Pseudoxanthoma Elasticum: Etidronate to the Rescue?
    Uitto J; Li Q
    J Am Coll Cardiol; 2018 Mar; 71(10):1127-1129. PubMed ID: 29519354
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene.
    Li Q; Sundberg JP; Levine MA; Terry SF; Uitto J
    Cell Cycle; 2015; 14(7):1082-9. PubMed ID: 25607347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates: from softening water to treating PXE.
    Moore SN; Tanner SB; Schoenecker JG
    Cell Cycle; 2015; 14(9):1354-5. PubMed ID: 25894689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vascular calcification in pseudoxanthoma elasticum in children].
    Dibi A; Mouane N; El Fahime E; Dafiri R; Bentahila A
    J Med Vasc; 2017 Dec; 42(6):333-337. PubMed ID: 29203039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of etidronate on choroidal neovascular activity in patients with pseudoxanthoma elasticum.
    Risseeuw S; van Leeuwen R; Imhof SM; de Jong PA; Mali WPTM; Spiering W; Ossewaarde-van Norel J
    PLoS One; 2020; 15(10):e0240970. PubMed ID: 33079965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periumbilical perforating pseudoxanthoma elasticum.
    Kocatürk E; Kavala M; Zindanci I; Koç M
    Indian J Dermatol Venereol Leprol; 2009; 75(3):329. PubMed ID: 19439905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stalactite in the aorta. Abnormal calcification in a patient with pseudoxanthoma elasticum.
    Wilhjelm JK; Sommerlund M; Andersen G; Andersen NH
    Acta Cardiol; 2017 Feb; 72(1):77-78. PubMed ID: 28597749
    [No Abstract]   [Full Text] [Related]  

  • 11. Dietary Pyrophosphate Modulates Calcification in a Mouse Model of Pseudoxanthoma Elasticum: Implication for Treatment of Patients.
    Pomozi V; Julian CB; Zoll J; Pham K; Kuo S; Tőkési N; Martin L; Váradi A; Le Saux O
    J Invest Dermatol; 2019 May; 139(5):1082-1088. PubMed ID: 30468740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated peripheral vascular aging in pseudoxanthoma elasticum - proof of concept for arterial calcification-induced cardiovascular disease.
    Bartstra JW; de Jong PA; Spiering W
    Aging (Albany NY); 2019 Feb; 11(3):1062-1064. PubMed ID: 30745467
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of pseudoxanthoma elasticum with tocopherol acetate and ascorbic acid.
    Takata T; Ikeda M; Kodama H; Kitagawa N
    Pediatr Dermatol; 2007; 24(4):424-5. PubMed ID: 17845175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoxanthoma elasticum.
    Fogelman JP
    Dermatol Online J; 2001 Dec; 7(2):16. PubMed ID: 12165232
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile pseudoxanthoma elasticum: recognition and management.
    Hacker SM; Ramos-Caro FA; Beers BB; Flowers FP
    Pediatr Dermatol; 1993 Mar; 10(1):19-25. PubMed ID: 8493160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early arterial calcification does not correlate with bone loss in pseudoxanthoma elasticum.
    Martin L; Hoppé E; Kauffenstein G; Omarjee L; Navasiolava N; Henni S; Willoteaux S; Leftheriotis G
    Bone; 2017 Oct; 103():88-92. PubMed ID: 28658601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of pyrophosphate inhibits connective tissue calcification.
    Dedinszki D; Szeri F; Kozák E; Pomozi V; Tőkési N; Mezei TR; Merczel K; Letavernier E; Tang E; Le Saux O; Arányi T; van de Wetering K; Váradi A
    EMBO Mol Med; 2017 Nov; 9(11):1463-1470. PubMed ID: 28701330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudoxanthoma elasticum].
    Bourgault I; Cosnes A; Revuz J
    Ann Dermatol Venereol; 1990; 117(2):133-7. PubMed ID: 2188551
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of pseudoxanthoma elasticum with probenecid.
    Osti MH; Scardamaglia L
    Australas J Dermatol; 2021 Aug; 62(3):440-441. PubMed ID: 33792919
    [No Abstract]   [Full Text] [Related]  

  • 20. Pseudoxanthoma elasticum.
    Tay CH
    Postgrad Med J; 1970 Feb; 46(532):97-108. PubMed ID: 5416513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.